Mycobacterium avium complex pulmonary disease patients with limited treatment options

• Stefano Aliberti,
• Francesco Blasi,
• Pierre-Régis Burgel,
• Andrea Calcagno,
• Andreas Fløe,
• Dorothy Grogono,
• Apostolos Papavasileiou,
• Eva Polverino,
• Concepción Prados,
• Gernot Rohde,
• Helmut J.F. Salzer,
• Adrián Sánchez-Montalvá,
• Michal Shteinberg,
• Eva Van Braeckel,
• Jakko van Ingen,
• Nicolas Veziris,
• Dirk Wagner,
• Michael R. Loebinger

Affiliations

Stefano Aliberti

Department of Biomedical Sciences, Humanitas University, Milan, Italy

Francesco Blasi

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy

Pierre-Régis Burgel

Respiratory Medicine, Université Paris Cité, Inserm U1016, Institut Cochin, Paris, France

Andrea Calcagno

Department of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy

Andreas Fløe

Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark

Dorothy Grogono

Cambridge Centre of Lung Infection, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK

Apostolos Papavasileiou

“Sotiria” General Hospital of Chest Diseases, Athens, Greece

Eva Polverino

Respiratory Medicine, Adult Bronchiectasis and Cystic Fibrosis, University Hospital Vall D'Hebron, VHIR, CIBERES, Barcelona, Spain

Concepción Prados

Pulmonology, Cystic fibrosis, Bronchiectasis, Bronquial Infections, La Paz University Hospital, Madrid, Spain

Gernot Rohde

Goethe University Frankfurt, University Hospital, Medical Clinic 1, Respiratory Medicine and Allergology, Frankfurt am Main, Germany

Helmut J.F. Salzer

Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine 4 - Pneumology, Kepler University Hospital, Linz, Austria

Adrián Sánchez-Montalvá

International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS, Universitat Autónoma de Barcelona, Barcelona, Spain

Michal Shteinberg

Carmel Medical Center and the Technion-Israel Institute of Technology, B. Rappaport Faculty of Medicine, Haifa, Israel

Eva Van Braeckel

Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium

Jakko van Ingen

Clinical Microbiologist, Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands

Nicolas Veziris

Sorbonne Université, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), UMR 1135, Department of Bacteriology, Saint-Antoine Hospital, APHP, Sorbonne-Université, Centre National de Référence des Mycobactéries, Paris, France

Dirk Wagner

Department of Internal Medicine II, Division of Infectious Diseases, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

Michael R. Loebinger

Host Defence Unit, Royal Brompton Hospital, and NHLI, Imperial College, London, United Kingdom